0001193125-19-135059 Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 2nd, 2019 • Novus Therapeutics, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 30, 2019, (the “Effective Date”) between Novus Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT NOVUS THERAPEUTICS, INC.
Common Stock Purchase Warrant • May 2nd, 2019 • Novus Therapeutics, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on (the “Termination Date”) but not thereafter, to subscribe for and purchase from Novus Therapeutics, Inc., a Delaware corporation (the “Company”), up to shares of Common Stock (the shares of Common Stock issuable upon exercise hereof being referred to as the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of April 22, 2019, and amended on April 29, 2019.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!